Evidence map›Paper›PMID 26742011›Full record

Trial reportBritish journal of cancer2016

Impact of general practice endorsement on the social gradient in uptake in bowel cancer screening.

Rosalind Raine, Stephen W Duffy, Jane Wardle, Francesca Solmi, Stephen Morris, Rosemary Howe, Ines Kralj-Hans, Julia Snowball, Nicholas Counsell, Sue Moss and 12 more

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in British journal of cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Optimizing the implementation of lung cancer screening in Scotland: Focus group participant perspectives in the LUNGSCOT study.Health expectations : an international journal of public participation in health care and health policy · 2022
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 11 institutions in 1 country.

Rosalind RaineDepartment of Applied Health Research, University College London, London WC1E 6BT, UK.
Stephen W DuffyCentre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London EC1M 6BQ, UK.
Jane WardleDepartment of Epidemiology and Public Health, University College London, London WC1E 6BT, UK.
Francesca SolmiDepartment of Applied Health Research, University College London, London WC1E 6BT, UK.
Stephen MorrisDepartment of Applied Health Research, University College London, London WC1E 6BT, UK.
Rosemary HoweDepartment of Surgery and Cancer, Imperial College London, London W2 1PG, UK.
Ines Kralj-HansDepartment of Biostatistics, King's Clinical Trials Unit, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK.
Julia SnowballNHS Bowel Cancer Screening Programme Southern Hub, Royal Surrey County Hospital NHS Foundation Trust, Guildford GU2 7YS, UK.
Nicholas CounsellCancer Research UK and University College London Cancer Trials Centre, London WC1E 6BT, UK.
Sue MossCentre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London EC1M 6BQ, UK.
Allan HackshawCancer Research UK and University College London Cancer Trials Centre, London WC1E 6BT, UK.
Christian von WagnerDepartment of Epidemiology and Public Health, University College London, London WC1E 6BT, UK.
Gemma VartDepartment of Epidemiology and Public Health, University College London, London WC1E 6BT, UK.
Lesley M McGregorDepartment of Epidemiology and Public Health, University College London, London WC1E 6BT, UK.
Samuel G SmithCentre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London EC1M 6BQ, UK.
Stephen HalloranNHS Bowel Cancer Screening Programme Southern Hub, Royal Surrey County Hospital NHS Foundation Trust, Guildford GU2 7YS, UK.
Graham HandleyNHS Bowel Cancer Screening Programme North East Hub, Gateshead Health NHS Foundation Trust, Queen Elizabeth Hospital, Gateshead NE9 6SX, UK.
Richard F LoganNHS Bowel Cancer Screening Programme Eastern Hub, Nottingham University Hospitals, Nottingham NG7 2UH, UK.
Sandra RainbowNHS Bowel Cancer Screening Programme London Hub, Northwick Park and St Mark's Hospitals NHS Trust, Middlesex HA1 3UJ, UK.
Steve SmithNHS Bowel Cancer Screening Programme Midlands and North West Hub, University Hospitals Coventry and Warwickshire NHS Trust, Hospital of St Cross, Rugby CV22 5PX, UK.
Mary C ThomasDepartment of Applied Health Research, University College London, London WC1E 6BT, UK.
Wendy AtkinDepartment of Surgery and Cancer, Imperial College London, London W2 1PG, UK.
University College London · GBImperial College London · GBQueen Mary University of London · GBRoyal Surrey County Hospital · GBGateshead Health NHS Foundation Trust · GBHospital of St. Cross · GBKing's College London · GBLondon Cancer · GBNottingham University Hospitals NHS Trust · GBSt Mark's Hospital · GBUniversity Hospitals Coventry and Warwickshire NHS Trust · GB

Funding

Cancer Research UK 14134Cancer Research UK 16894Cancer Research UK 17965Cancer Research UK A17965Department of Health RP-PG-0609-10106
6 · The paper itself

Abstract

backgroundThere is a socioeconomic gradient in the uptake of screening in the English NHS Bowel Cancer Screening Programme (BCSP), potentially leading to inequalities in outcomes. We tested whether endorsement of bowel cancer screening by an individual's general practice (GP endorsement; GPE) reduced this gradient.

methodsA cluster-randomised controlled trial. Over 20 days, individuals eligible for screening in England from 6480 participating general practices were randomly allocated to receive a GP-endorsed or the standard invitation letter. The primary outcome was the proportion of people adequately screened and its variation by quintile of Index of Multiple Deprivation.

resultsWe enrolled 265,434 individuals. Uptake was 58.2% in the intervention arm and 57.5% in the control arm. After adjusting for age, sex, hub and screening episode, GPE increased the overall odds of uptake (OR=1.07, 95% CI 1.04-1.10), but did not affect its socioeconomic gradient. We estimated that implementing GPE could result in up to 165 more people with high or intermediate risk colorectal adenomas and 61 cancers detected, and a small one-off cost to modify the standard invitation (£78,000).

conclusionsAlthough GPE did not improve its socioeconomic gradient, it offers a low-cost approach to enhancing overall screening uptake within the NHS BCSP.

Indexed as

Healthcare DisparitiesAdenomaAgedAttitude of Health PersonnelCarcinomaColonoscopyColorectal NeoplasmsCommunicationEarly Detection of CancerEnglandFemaleGeneral PracticeHumansMaleMiddle AgedOccult Blood

Identifiers

PMID26742011
PMCPMC4742577
OpenAlexW2227186431

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.